Myosin IE (MYO1E) (Middle Region) Peptid
MYO1E
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle MYO1E Produkte
- MYO1E (Myosin IE (MYO1E))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MYO1E antibody (Catalog #: ARP56601_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MYO1E (Myosin IE (MYO1E))
- Synonyme
- FSGS6 Peptide, HuncM-IC Peptide, MYO1C Peptide, MYR5 Peptide, Myr3 Peptide, 2310020N23Rik Peptide, 9130023P14Rik Peptide, AA407778 Peptide, myosin-1e Peptide, myr 3 Peptide, myo1e Peptide, wu:fc15g04 Peptide, wu:fe49h01 Peptide, myosin IE Peptide, myosin IE, a Peptide, MYO1E Peptide, Myo1e Peptide, myo1ea Peptide
- Hintergrund
-
Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments.
Alias Symbols: HuncM-IC, MGC104638, MYO1C, FSGS6
Protein Interaction Partner: ACTB
Protein Size: 1108 - Molekulargewicht
- 127 kDa
- Gen-ID
- 4643
- NCBI Accession
- NM_004998, NP_004989
- UniProt
- Q12965
-
Sie sind hier:
